000 02474nam a22002657a 4500
003 OSt
005 20240305193738.0
008 221126b |||||||| |||| 00| 0 eng d
028 _b Phone: +255 28 298 3384
028 _b Fax: +255 28 298 3386
028 _b Email: vc@bugando.ac.tz
028 _b Website: www.bugando.ac.tz
040 _bEnglish
_cDLC
041 _aEnglish
100 _aMaryam Amour
_945555
245 _aMedical management of acute loss of vision in tuberculous meningitis: A case report
260 _aMwanza, Tanzania:
_b Elsevier &
_bCatholic University of Health and Allied Sciences [CUHAS – Bugando]
_c2020/5/1
300 _aPages 100145
490 _vJournal of Clinical Tuberculosis and Other Mycobacterial Diseases Volume 19
520 _a Abstract: Objectives: Intravesical Bacillus Calmette-Guérin (BCG) treatment for superficial bladder cancer is interrupted in approximatively 8% of cases as a result of complications. The objective is to report the severe related complications of Bacillus Calmette-Guérin (BCG) following an intravesical instillation for bladder tumor encountered at our institution for the past 5 years. Methods: Medical records of a tertiary teaching hospital, located in Beirut, Lebanon, were retrospectively analyzed from June 2014 to June 2019 searching for severe related complications of BCG. A comprehensive review of articles on this subject was conducted. Results:The incidence of severe systemic adverse events related to BCG instillation was 1.5% (5 out of 332 patients). A total of five patients were found to have a severe BCG related complication, with fever, chills, and irritative urinary signs being the most frequent symptoms. All patients received antituberculosis therapy (Isoniazid, Rifampin and Ethambutol). Two were put on add-on corticosteroids. Three patients had a computed tomography scan image in favor of an infection. Two patients had a favorable outcome, three patients died. Conclusion: BCG severe adverse events were mostly seen in patients with a traumatic instillation. Treatment used at our institution was similar to most cases reported in the literature. A standardized diagnostic and treatment approach should be implemented to help physicians tackle these life-threatening complications.
700 _aSarah Shali Matuja
_946032
700 _aJerome H Chin
_946035
856 _uhttps://doi.org/10.1016/j.jctube.2020.100145
942 _2ddc
_cVM
999 _c19732
_d19732